Mainsail Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$999K Buy
4,087
+776
+23% +$181K 0.45% 29
2025
Q4
$685K Sell
3,311
-458
-12% -$90.6K 0.29% 35
2025
Q3
$699K Buy
3,769
+1,685
+81% +$289K 0.31% 38
2025
Q2
$318K Hold
2,084
0.2% 42
2025
Q1
$346K Buy
2,084
+163
+8% +$25.5K 0.24% 41
2024
Q4
$278K Hold
1,921
0.19% 50
2024
Q3
$311K Hold
1,921
0.23% 41
2024
Q2
$281K Hold
1,921
0.22% 42
2024
Q1
$304K Hold
1,921
0.25% 37
2023
Q4
$301K Buy
+1,921
New +$295K 0.28% 34

Other funds holding JNJ

Mainsail Asset Management's JNJ Position: Q1 2026 in Review

Mainsail Asset Management increased its Johnson & Johnson (JNJ) stake by 23% in Q1 2026, buying an estimated $181K and bringing the position to 4,087 shares worth $999K. The position accounts for 0.45% of the portfolio, ranked #29.

Mainsail Asset Management first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Mainsail Asset Management held 4,087 shares of Johnson & Johnson worth $999K as of Q1 2026.
  • Mainsail Asset Management bought 776 Johnson & Johnson shares in Q1 2026, an estimated $181K.
  • Johnson & Johnson made up 0.45% of Mainsail Asset Management's portfolio in Q1 2026, its #29 holding.
  • Mainsail Asset Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Mainsail Asset Management's 13F filing for Q1 2026, filed 13 May 2026.